- Report
- September 2026
- 192 Pages
Global
From €3269EUR$3,545USD£2,771GBP
€3632EUR$3,939USD£3,079GBP
- Report
- September 2026
- 196 Pages
Global
From €3269EUR$3,545USD£2,771GBP
€3632EUR$3,939USD£3,079GBP
- Report
- September 2026
- 198 Pages
Global
From €3269EUR$3,545USD£2,771GBP
€3632EUR$3,939USD£3,079GBP
- Report
- September 2026
- 197 Pages
Global
From €3269EUR$3,545USD£2,771GBP
€3632EUR$3,939USD£3,079GBP
- Report
- September 2026
- 196 Pages
Global
From €3269EUR$3,545USD£2,771GBP
€3632EUR$3,939USD£3,079GBP
- Report
- September 2026
- 185 Pages
Global
From €3269EUR$3,545USD£2,771GBP
€3632EUR$3,939USD£3,079GBP
- Report
- January 2026
- 189 Pages
Global
From €3269EUR$3,545USD£2,771GBP
€3632EUR$3,939USD£3,079GBP
- Report
- January 2026
- 105 Pages
Global
From €4380EUR$4,750USD£3,713GBP
- Report
- July 2026
- 116 Pages
Global
From €4380EUR$4,750USD£3,713GBP
- Report
- April 2026
- 160 Pages
Global
From €3061EUR$3,320USD£2,595GBP
€3826EUR$4,150USD£3,244GBP
- Report
- August 2026
- 182 Pages
Global
From €2213EUR$2,400USD£1,876GBP
- Report
- August 2026
- 181 Pages
Global
From €3642EUR$3,950USD£3,088GBP
- Report
- August 2026
- 183 Pages
Global
From €3642EUR$3,950USD£3,088GBP
- Report
- August 2026
- 180 Pages
Global
From €3642EUR$3,950USD£3,088GBP
- Report
- August 2026
- 148 Pages
Global
From €3642EUR$3,950USD£3,088GBP
- Report
- August 2026
- 180 Pages
Global
From €3642EUR$3,950USD£3,088GBP
- Report
- August 2026
- 179 Pages
Global
From €3642EUR$3,950USD£3,088GBP
- Report
- August 2026
- 184 Pages
Global
From €3642EUR$3,950USD£3,088GBP
- Report
- August 2026
- 176 Pages
Global
From €3642EUR$3,950USD£3,088GBP
- Report
- August 2026
- 176 Pages
Global
From €3642EUR$3,950USD£3,088GBP

Translational Medicine is a field of biotechnology that focuses on the development of treatments and therapies for diseases and medical conditions. It involves the translation of basic research findings into clinical applications, such as the development of new drugs, diagnostics, and medical devices. Translational Medicine also involves the development of new methods for clinical trials and the evaluation of existing treatments.
The Translational Medicine market is driven by the need for new treatments and therapies for diseases and medical conditions. It is also driven by the need for improved diagnostics and medical devices. The market is expected to grow as new treatments and therapies are developed and as existing treatments are evaluated.
Some companies in the Translational Medicine market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more